New Company Formed with $130 Million to Accelerate Duke’s Drug Discovery
DURHAM, N.C., and NEW YORK, N.Y. — Duke University and Deerfield Management Company, a healthcare investment firm, announced Wednesday the creation of a major translational research collaboration. Spearheaded by Duke University’s Office of Licensing & Ventures (OLV), the alliance is expected to accelerate Duke’s preclinical development of new drugs for improved quality of life and cures for…